From £6.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £6.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Latest Views & News

SYME
premium content

Tick Tock, clock now running at Companies House for the Supply@ME fraud

As you can see below, at Companies House, the auditor’s resignation letter for the fraud Supply@ME Capital (SYME) is now being processed and will be available in a few days. Supply made the following statement about the resignation:
TRAF
premium content

Trafalgar Property – Emerges From Suspension Following Disastrous Results And Abandoned RTO…..Still A Bargepole Sell

AIM-listed (still!) Trafalgar Property (TRAF) saw its shares suspended back in May with a proposed reverse takeover, as detailed by Tom Winnifrith. But the deal fell through (quelle surprise, given the company’s dire balance sheet) and following its results to March 2024, released at the end of September, the suspension was lifted on 1st October with the announcement that the RTO was off. But why?
Professor

Visual Aid: The Most Popular Investing Strategies, by Generation

When it comes to investing, each generation has their own mix of strategies, and younger generations like to try a bit of everything. This graphic visualizes the breakdown of how each generation uses each of the following types of investing strategies.

Gold
premium content

The View From The Montana Log-Cabin As Gold Holds Steady - $3,000 Still Beckons

Gold closed the week at $2,653 – hardly changed on last week’s $2,658 although Gold stocks dropped more, as can be seen on the chart below of Gold vs the mining ETFs GDX (majors), GDXJ (juniors) and GOEX (explorers).
Professor
premium content

Sunday Long Reads: Russia’s Delusions, Students who can’t Read, Kris Kristofferson, Serious Things, ENRC

Sunday is a good time to sit back, read, and forget about shares. Put the kettle on, find a comfy chair. You have the time, don't you? Featuring two updates this week.

Quiz
premium content

The ShareProphets Sunday Pub Quiz #261

It's time for the ShareProphets Sunday Pub Quiz. There are still no prizes! And remember, no Googling!

Top-10

Notes from Underground – Most read articles for the week ending Oct 5

The most read non-Tom article last week is The View From The Montana Log-Cabin As Gold Stalls Below $2,700, but $3,000 still in play as near term target by Nigel Somerville at number 1 or number 4 including Bearcasts.

SBTX
premium content

Just flagging up that the bearded loon has called an Investor Meet on 11 October

No not Darren Atwater. I refer instead to the Geordie poltroon, Stuart Ashman of Skinbiotherapeutics (SBTX) where I remain, of course, a loyal shareholder.
Bearcast
premium content

Tom Winnifrith Bearcast: wrestling with the moral dilemma of a sick CEO

I cannot name him or the company for reasons I explain but the company really should be coming clean 
TST
premium content

Touchstar – after interims, now again a Buy?

Mobile data computing and managed services company Touchstar (TST) recently announced half-year results including “the results are below H1 2023… pre-tax profits fell by 17.3% to £254,000”. However, we concur that the company “has demonstrated a high quality of earnings, a proven record of good growth and strong cash generation” – and consider there is now good reason to believe those will be realised from a 110p offer share price.
BP.
premium content

BP or Not BP. There's Probably No Question.

Hello Share Pushers. The obscene war in the Middle East has not really affected the price of oil. You would expect it to have risen sharply on the escalating hostilities, but it’s still weak compared to a year ago. But with Iran out of the equation I would expect the oil price to rise soon.
Bearcast
premium content

Tom Winnifrith Bearcast: The person from Porlock was the mother in law

I start with my mother in law and why the bearcast was late. I reflect on Inheritance Tax for that is what she wants to discuss. Then it is onto Powerhouse Energy (PHE), Versarien (VRS), Hydrogen Utopia (HUI), TekCapital (TEK) and MicroSalt (SALT)
Price-Vs-Value

ShareProphets readers tips for 2024 prize competition – (just under) three months to go update

Having asked for readers tips for 2024 for the prize of 1/4 litre of Tom Winnifrith's Greek Hovel olive oil (2024 harvest) HERE, the following is a (just under) three months to go update (to be eligible needed to have selected, on a once per username basis, one buy & one sell pick from the LSE or AIM casino and the stocks not to have been suspended at the commencement of 2024).

ZTF
premium content

Zotefoams – a continuing progress, but lower share price, Buy

Writing earlier this year on cellular materials technology company Zotefoams (ZTF), we considered there clear further upside potential including from accelerating and de-risking its proprietary technology, ‘ReZorce’ – with this substrate being developed for fully recyclable beverage cartons then being produced and quality and compliance testing procedures being initiated. However, a then more than 42% less than four months gain saw us take profits at a 524p bid price. Since then, the company’s first half of 2024 results have emphasised “preparing for market trial of 150,000 sterile juice cartons in Western Europe. Exploring strategic investment partnership during H2 2024 to facilitate the scale-up and delivery of the ReZorce solution globally” and “continued progress, with the benefits of our diverse market profile providing both stability and opportunities to unlock growth in a mixed economic backdrop”…yet the shares have fallen well below 450p. Here’s why we consider they can exceed the 570p they did in June, again.
OPTI
premium content

OptiBiotix Health – disappointing interim numbers but there is an explanation, risk/reward Buy

OptiBiotix Health (OPTI) has announced results for the first half of 2024 including “reported revenues decreased by 21.3% to £276K” but also “significantly increased order book and solid sales performance”, so what’s going on here?
VINO
premium content

Virgin Wines UK – “strategic partnership” with “the world's largest dedicated online supermarket”. Ramptastic?

Online wine retailer Virgin Wines UK (VINO) has issued a “Strategic Partnership with Ocado.com”-titled announcement detailing that it will provide customers of “the world's largest dedicated online supermarket” with a selection of wines previously available only to Virgin Wines customers and as part of multi-bottle cases, emphasising “this marks the first time these wines will be offered as individual bottles”. What about a current 2.5% higher share price to 40.5p in response?
Clown
premium content

A failed fund manager lashes out at those who cannot forecast for toffee

No not me silly, it is disgraced Neil Woodford. And he is not attacking himself and his own dire predictive skills but, for once, I agree with him as he lays into the OBR and the Bank of England.
BMV
premium content

Is Bluebird a fraud making things up?

Of course, it is not and it is not but that is pretty much the accusation being made by Show Me the cash on this website’s comments section and by, I suspect, the same poster on the LSE Asylum. I have chatted to the company.
Bearcast
premium content

Tom Winnifrith bonus bearcast: the bollocks of a Versarien corporate update

Well done evil PR genius Tim Metcalfe, you fooled the morons with this one but today's update is pure bollocks. Now it is placing ahoy.
TEK
premium content

China fraud fan puts the bull case for TekCapital: Chronic Investing

I seem to remember that Simon Thompson of the Investors Chronicle was a big fan of most of the AIM listed China frauds. He is also a very stale, long and wrong, bull of TekCapital (TEK). In this week’s magazine he, again, puts the bull case and here is that bull case and why it is just so wrong. The Chronic Investor’s comments are below with my comments in bold.
Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

 

HEMO

Hemogenyx is a short – target 0p

 

ECR

ECR, the timing is unfortunate

 

APH

Alliance Pharma – a recovery Buy?

 

PICH

Pitch Pit – this stinks

 

GEX

Georgina Energy: Lyin’ Yet again

Time left: 21:18:33